Pulse Biosciences (PLSE) Total Non-Current Liabilities (2020 - 2025)
Pulse Biosciences has reported Total Non-Current Liabilities over the past 6 years, most recently at $16.1 million for Q3 2025.
- Quarterly results put Total Non-Current Liabilities at $16.1 million for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $16.1 million (changed N/A YoY), and the annual figure for FY2024 was $17.6 million, up 18.95%.
- Total Non-Current Liabilities for Q3 2025 was $16.1 million at Pulse Biosciences, up from $15.8 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for PLSE hit a ceiling of $81.4 million in Q3 2022 and a floor of $13.8 million in Q3 2023.
- Median Total Non-Current Liabilities over the past 5 years was $17.4 million (2022), compared with a mean of $31.3 million.
- Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 497.24% in 2021 and later tumbled 83.04% in 2023.
- Pulse Biosciences' Total Non-Current Liabilities stood at $14.8 million in 2021, then surged by 441.6% to $80.1 million in 2022, then plummeted by 81.54% to $14.8 million in 2023, then increased by 18.95% to $17.6 million in 2024, then fell by 8.68% to $16.1 million in 2025.
- The last three reported values for Total Non-Current Liabilities were $16.1 million (Q3 2025), $15.8 million (Q2 2025), and $14.9 million (Q1 2025) per Business Quant data.